Showing results (101-110 of 651) with videos related to
Sort By:
Pageof 66
Neuropsychopharmacology Reports|October 21, 2018
The influence of tightening regulations on patients with new psychoactive substance-related disorders in JapanYuko Tanibuchi, Toshihiko Matsumoto, Daisuke Funada, et al.Neuropsychopharmacology Reports|July 21, 2019
Concurrent, successful management of bipolar I disorder with comorbid alcohol dependence via aripiprazole long-acting injection: A case reportTsutomu Kurata, Tasuku Hashimoto, Hitoshi SuzukiNeuropsychopharmacology Reports|March 11, 2023
Sleep disturbance after cessation of cannabis administration in miceTakashi Asano, Hiroki Takemoto, Tomoya Horita, et al.Neuropsychopharmacology Reports|August 26, 2025
Successful Early Treatment of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Associated With Small Cell Lung Cancer in an Elderly Male Patient: A Case ReportKohei Kamikawa, Ryohei Takada, Yuya Honda, et al.Neuropsychopharmacology Reports|February 17, 2026
Prolonged Anti-Zic4 Antibody-Positive Cerebellar Degeneration Following COVID-19 InfectionRisa Suzuki-Yamamoto, Asuka Nakajima, Tsuyoshi Furuya, et al.Neuropsychopharmacology Reports|January 19, 2026
How Does the Public Perceive the Functions of Non-Suicidal Self-Injury? An Analysis by Gender and Age GroupMasaru TakahashiNeuropsychopharmacology Reports|January 9, 2026
Disruption of the l-DOPA Receptor Gpr143/OA1-Gene in Mice Creates a Unique Mixed Psychosis-Like PhenotypeYoshio Goshima, Haruko Nakamura, Motokazu Koga, et al.Neuropsychopharmacology Reports|March 20, 2023
Efficacy and safety of adding fluoxetine to the treatment regimen of hospitalized patients with non-critical COVID-19 pneumonia: A double-blind randomized, placebo-controlled clinical trialFaranak Sedighi, Mehran Zarghami, Fatemeh Alizadeh Arimi, et al.Neuropsychopharmacology Reports|July 17, 2020
Is intensive case management screening sheet score associated with service intensity?Sosei Yamaguchi, Yasunari Kawasoe, Kazumi Nayuki, et al.Pageof 66